Asterias Biotherapeutics Inc. Common Series A

(AST)

By |

Profile

Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The company has two core technology platforms. The first is an immunotherapy platform to teach cancer patients immune systems to attack their tumors. The second is pluripotent stem cell platform. From immunotherapy platform it is developing AST-VAC1, an autologous product candidate for the treatment of acute myelogenous leukemia; and AST-VAC2, an allogeneic, cancer vaccine candidate designed to stimulate patient immune responses; and through pluripotent it has developed AST-OPC1, which is for the treatment of spinal cord injury, multiple sclerosis, and stroke. All the activities of the firm are operated through United States.

Contact Information

Website: www.asteriasbiotherapeutics.com
Email: InvestorRelations@asteriasbio.com
Main Phone: +1 510 456-3800
Address: 6300 Dumbarton Circle
State: CA
City / Town: Fremont
Country: USA
Postal Code: 94555

Issuer Information

Exchange: AMX
CEO: Michael Mulroy
Employees: 31
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The company has two core technology platforms. The first is an immunotherapy platform to teach cancer patients immune systems to attack their tumors. The second is pluripotent stem cell platform. From immunotherapy platform it is developing AST-VAC1, an autologous product candidate for the treatment of acute myelogenous leukemia; and AST-VAC2, an allogeneic, cancer vaccine candidate designed to stimulate patient immune responses; and through pluripotent it has developed AST-OPC1, which is for the treatment of spinal cord injury, multiple sclerosis, and stroke. All the activities of the firm are operated through United States.

Contact Information

Website: www.asteriasbiotherapeutics.com
Email: InvestorRelations@asteriasbio.com
Main Phone: +1 510 456-3800
Address: 6300 Dumbarton Circle
State: CA
City / Town: Fremont
Country: USA
Postal Code: 94555

Issuer Information

Exchange: AMX
CEO: Michael Mulroy
Employees: 31
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.77 $ 0.0135 (1.78%)
Last Price 0.77 Change $ 0.0135 Change % 1.78 Tick N/A
Bid 0.77 Bid Size 400.00 Ask 0.77 Ask Size 4,800.00
Open 0.75 High 0.82 Low 0.75 Prev Close 0.76
Last Trade Volume 66,363 52 Wk Hi 2.55 52 Wk Low 0.51
Market Cap 42.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 55,658,684.00 EPS (TTM) -0.37 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 1
Number of Buys 0 1
Number of Sells 0 0
Net Activity 0 1592308
Last 10 Buys Shares
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Don M. Bailey 1,000
Richard T. LeBuhn 1,000
Natale S. Ricciardi 1,000
Andrew Arno 1,000
Alfred D. Kingsley 1,000
Last 10 Sell Shares
Jane S. Lebkowski 1,000
Edward Wirth 1,000
Katharine E. Spink 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 13 13 13 13
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 7.9 7.9 7.9 7.9
Standard Deviation 3.88 3.88 3.88 3.88
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 4
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.25 1.25 1.2